Post-COVID Insomnia Treatment
Cognitive Behavioral Therapy for Insomnia (CBT-I) should be the first-line treatment for post-COVID insomnia, with pharmacological therapy reserved only as a last resort after behavioral interventions have been exhausted. 1, 2
Initial Assessment and Recognition
Post-COVID insomnia is highly prevalent, affecting approximately 40-50% of patients recovering from COVID-19 infection, with symptoms persisting beyond 12 months in approximately 28% of cases. 3, 4, 5 Key features to identify include:
- Difficulty initiating sleep (reported in 39% post-COVID vs 31% pre-COVID) 5
- Difficulty maintaining sleep (57% post-COVID vs 43% pre-COVID) 5
- Increased need for napping and decreased feeling of being rested 5
- Strong association with anxiety and depression symptoms 4
Important predictors of chronic insomnia include female sex, younger age, non-White race, and lower BMI. 3, 4
Treatment Algorithm
Step 1: Non-Pharmacological Interventions (First-Line)
Cognitive Behavioral Therapy for Insomnia (CBT-I) is the primary evidence-based treatment:
- Digital CBT-I delivered via telehealth has demonstrated significant efficacy, reducing insomnia severity scores from 24 to 12 (p=0.036) in post-COVID patients. 3
- CBT-I improves not only insomnia symptoms but also mediates subsequent improvement in depressive symptoms (b=2.10, p=0.024). 2
- Treatment effects persist across 28 weeks, even when delivered during ongoing pandemic stressors. 2
- Four sessions over five weeks represents an effective treatment duration. 2
Specific CBT-I components to implement:
- Sleep hygiene education - addressing patient behavior and dietary factors 1
- Stimulus control therapy - reconditioning the bed/bedroom as cues for sleep 1
- Sleep restriction therapy - limiting time in bed to actual sleep time 1
- Relaxation techniques - progressive muscle relaxation, breathing exercises 1
Step 2: Adjunctive Non-Pharmacological Tools
Additional evidence-based interventions:
- Heart coherence techniques - breathing-based interventions to regulate autonomic nervous system 1
- Neurofeedback - emerging tool for sleep regulation 1
- Psychological counseling and mental health education - particularly important given the strong correlation between insomnia and anxiety/depression in post-COVID patients 6, 4
Step 3: Address Comorbid Psychiatric Symptoms
Screen and treat concurrent mental health conditions:
- Anxiety and depression are strong correlates with worse insomnia severity 4
- Improvements in anxiety and PTSD scores correlate with interval improvements in insomnia 4
- Consider non-drug treatments including Tai Chi, breathing relaxation training, mindfulness training, and cognitive behavioral therapy for anxiety and depression 6
Step 4: Pharmacological Treatment (Last Resort Only)
Hypnotics should only be prescribed when behavioral interventions have failed, given undesirable side effects and the potential for avoiding many prescriptions through proper education and behavioral tools. 1
When pharmacological treatment is absolutely necessary:
- Use the lowest effective dose for the shortest duration possible
- Regularly reassess the need for continuation
- Prioritize medications with lower dependence potential
Common Pitfalls to Avoid
Do not immediately prescribe sleep medications - The evidence strongly supports behavioral interventions first, and many pharmacological prescriptions could be avoided with proper patient education. 1
Do not ignore psychiatric comorbidities - Insomnia severity is strongly linked to anxiety and depression; treating insomnia alone without addressing mood may result in incomplete recovery. 4
Do not assume physiological COVID sequelae correlate with insomnia - Cardiopulmonary symptoms and physiological functions (like 6-minute walk distance) do not correlate with insomnia severity, suggesting the mechanism is primarily neuropsychiatric rather than physiological. 4
Do not expect rapid spontaneous resolution - Insomnia symptoms remain stable from 3 to 12 months post-COVID, indicating chronicity and the need for active intervention rather than watchful waiting. 3
Follow-Up and Monitoring
- Reassess at 3-month intervals using validated tools like the Insomnia Severity Index (ISI) or Bergen Insomnia Scale (BIS) 3, 4
- Monitor for persistence beyond 12 months, which occurs in approximately 28% of patients 5
- Track concurrent improvements in anxiety, depression, and PTSD symptoms as these correlate with insomnia improvement 4
- Be aware that only 50% of patients may complete full CBT-I protocols, necessitating strategies to improve adherence 3